Abstract
Rapid antigen tests are widely used to diagnose infection with SARS-CoV-2, and millions of kits have been distributed for free by government agencies. However, unused and expired kits beyond their final expiration dates remain prevalent in people’s homes. This study aimed to determine the accuracy of expired BinaxNOW COVID rapid antigen test kits. 100 expired and 100 unexpired test kits were checked for sensitivity and specificity using positive and negative controls, respectively. The results showed that there was no change in the sensitivity and specificity of BinaxNOW COVID rapid antigen test kits four months beyond the manufacturer-extended expiration date when using manufacturer-provided positive controls. The findings provide confidence in the accuracy of expired test kits, which could potentially reduce waste and strengthen supply chain resilience for pandemic preparedness. Further research utilizing actual human specimens can help determine the true accuracy of expired rapid antigen test kits in clinical use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
